Yu-Wen Alvin Huang

Dr. Yu-Wen Alvin Huang

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2022 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
KCKevin Connolly
Kevin Connolly
MLMikael Lehoux
Mikael Lehoux
RORyan O'ROurke
Ryan O'ROurke
BABenedetta Assetta
Benedetta Assetta
GEGuzide Ayse Erdemir
Guzide Ayse Erdemir
YHYu-Wen Alvin Huang
Yu-Wen Alvin Huang

22 July 2019 in The Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
YHYu-Wen Alvin Huang
Yu-Wen Alvin Huang
BZBo Zhou
Bo Zhou
ANAmber M. Nabet
Amber M. Nabet
MWMarius Wernig
Marius Wernig
TSThomas C. Südhof
Thomas C. Südhof
In blood, apolipoprotein E (ApoE) is a component of circulating lipoproteins and mediates the clearance of these lipoproteins from blood by binding to ApoE receptors. Humans express three genetic ApoE variants, ApoE2, ApoE3, and ApoE4, which exhibit distinct ApoE receptor-binding properties and differentially affect Alzheimer9s disease (AD), such that ApoE2 protects against, and ApoE4 predisposes to AD. In brain, ApoE-containing lipoproteins are secreted by activated astrocytes and microglia, but their functions and role in AD pathogenesis are largely unknown. Ample evidence suggests that ApoE4 induces microglial dysregulation and impedes Aβ clearance in AD, but the direct neuronal effects of ApoE variants are poorly studied. Extending previous studies, we here demonstrate that the three ApoE variants differentially activate multiple neuronal signaling pathways and regulate synaptogenesis. Specifically, using human neurons (male embryonic stem cell-derived) cultured in the absence of glia to exclude indirect glial mechanisms, we show that ApoE broadly stimulates signal transduction cascades. Among others, such stimulation enhances APP synthesis and synapse formation with an ApoE4>ApoE3>ApoE2 potency rank order, paralleling the relative risk for AD conferred by these ApoE variants. Unlike the previously described induction of APP transcription, however, ApoE-induced synaptogenesis involves CREB activation rather than cFos activation. We thus propose that in brain, ApoE acts as a glia-secreted signal that activates neuronal signaling pathways. The parallel potency rank order of ApoE4>ApoE3>ApoE2 in AD risk and neuronal signaling suggests that ApoE4 may in an apparent paradox promote AD pathogenesis by causing a chronic increase in signaling, possibly via enhancing APP expression. SIGNIFICANCE STATEMENT Humans express three genetic variants of apolipoprotein E (ApoE), ApoE2, ApoE3, and ApoE4. ApoE4 constitutes the most important genetic risk factor for Alzheimer9s disease (AD), whereas ApoE2 protects against AD. Significant evidence suggests that ApoE4 impairs microglial function and impedes astrocytic Aβ clearance in brain, but the direct neuronal effects of ApoE are poorly understood, and the differences between ApoE variants in these effects are unclear. Here, we report that ApoE acts on neurons as a glia-secreted signaling molecule that, among others, enhances synapse formation. In activating neuronal signaling, the three ApoE variants exhibit a differential potency of ApoE4>ApoE3>ApoE2, which mirrors their relative effects on AD risk, suggesting that differential signaling by ApoE variants may contribute to AD pathogenesis.

25 May 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CPChangHui Pak
ChangHui Pak
TDTamas Danko
Tamas Danko
VMVincent R. Mirabella
Vincent R. Mirabella
JWJinzhao Wang
Jinzhao Wang
YLYingfei Liu
Yingfei Liu
TSThomas C. Südhof
Thomas C. Südhof
Significance: HeterozygousNRXN1deletions predispose to schizophrenia and other neurodevelopmental disorders. Engineered heterozygousNRXN1deletions impair neurotransmitter release in human neurons, suggesting a synaptic pathophysiological mechanism. In a multicenter effort to test the generality and robustness of this pivotal observation, we used, at two laboratories, independent analyses of patient-derived and newly engineered human neurons with heterozygousNRXN1deletions. Schizophrenia patient-derived neurons withNRXN1deletions exhibited the same major decrease in neurotransmitter release and an increase in CASK protein as engineered human neurons withNRXN1deletions. Strikingly, engineered mouseNrxn1-deficient neurons derived by the same method displayed no such phenotype, suggesting a human-specific role forNRXN1. Thus, heterozygousNRXN1deletions robustly impair synaptic function in human neurons, enabling future drug discovery efforts.

29 September 2023 in Science Advances
Verified
Journal Article
Open access
WJWei Jiang
Wei Jiang
FZFan Zhu
Fan Zhu
HXHuiming Xu
Huiming Xu
LXLi Xu
Li Xu
HLHaoyang Li
Haoyang Li
CTChangyong Tang
Changyong Tang
Chitinase-3–like protein 1 (CHI3L1) is primarily secreted by activated astrocytes in the brain and is known as a reliable biomarker for inflammatory central nervous system (CNS) conditions such as neurodegeneration and autoimmune disorders like neuromyelitis optica (NMO). NMO is an astrocyte disease caused by autoantibodies targeting the astroglial protein aquaporin 4 (AQP4) and leads to vision loss, motor deficits, and cognitive decline. In this study examining CHI3L1’s biological function in neuroinflammation, we found that CHI3L1 expression correlates with cognitive impairment in our NMO patient cohort. Activated astrocytes secrete CHI3L1 in response to AQP4 autoantibodies, and this inhibits the proliferation and neuronal differentiation of neural stem cells. Mouse models showed decreased hippocampal neurogenesis and impaired learning behaviors, which could be rescued by depleting CHI3L1 in astrocytes. The molecular mechanism involves CHI3L1 engaging the CRTH2 receptor and dampening β-catenin signaling for neurogenesis. Blocking this CHI3L1/CRTH2/β-catenin cascade restores neurogenesis and improves cognitive deficits, suggesting the potential for therapeutic development in neuroinflammatory disorders.

1 August 2024 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
CPChunte Sam Peng
Chunte Sam Peng
YZYunxiang Zhang
Yunxiang Zhang
QLQian Liu
Qian Liu
GMG. Edward Marti
G. Edward Marti
YHYu-Wen Alvin Huang
Yu-Wen Alvin Huang
SCSteven Chu
Steven Chu
Cytoplasmic dynein is essential for intracellular transport. Despite extensive in vitro characterizations, how the dynein motors transport vesicles by processive steps in live cells remains unclear. To dissect the molecular mechanisms of dynein, we develop optical probes that enable long-term single-particle tracking in live cells with high spatiotemporal resolution. We find that the number of active dynein motors transporting cargo switches stochastically between one and five dynein motors during long-range transport in neuronal axons. Our very bright optical probes allow the observation of individual molecular steps. Strikingly, these measurements reveal that the dwell times between steps are controlled by two temperature-dependent rate constants in which two ATP molecules are hydrolyzed sequentially during each dynein step. Thus, our observations uncover a previously unknown chemomechanical cycle of dynein-mediated cargo transport in living cells.

24 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
KWKonrad W. Walek
Konrad W. Walek
SSSabina Stefan
Sabina Stefan
JLJang-Hoon Lee
Jang-Hoon Lee
PPPooja Puttigampala
Pooja Puttigampala
AKAnna H. Kim
Anna H. Kim
JLJonghwan Lee
Jonghwan Lee
In age-related neurodegenerative diseases, pathology often develops slowly across the lifespan. As one example, in diseases such as Alzheimer’s, vascular decline is believed to onset decades ahead of symptomology. However, challenges inherent in current microscopic methods make longitudinal tracking of such vascular decline difficult. Here, we describe a suite of methods for measuring brain vascular dynamics and anatomy in mice for over seven months in the same field of view. This approach is enabled by advances in optical coherence tomography (OCT) and image processing algorithms including deep learning. These integrated methods enabled us to simultaneously monitor distinct vascular properties spanning morphology, topology, and function of the microvasculature across all scales: large pial vessels, penetrating cortical vessels, and capillaries. We have demonstrated this technical capability in wild-type and 3xTg male mice. The capability will allow comprehensive and longitudinal study of a broad range of progressive vascular diseases, and normal aging, in key model systems.